In:
Cancer, Wiley, Vol. 128, No. 18 ( 2022-09-15), p. 3319-3329
Abstract:
Hematologic malignancies and their treatments impaired humoral immunity from coronavirus disease 2019 vaccination, and booster vaccine overcame a lack of initial response in 58% of patients, including 63% those on active therapy. The findings indicated that booster vaccinations should be strongly encouraged; however, even with boosters, many remain unprotected, which should inform infection prevention and treatment strategies.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
DOI:
10.1002/cncr.v128.18
Language:
English
Publisher:
Wiley
Publication Date:
2022
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1
Permalink